367
Views
57
CrossRef citations to date
0
Altmetric
Original Article

Autologous mesenchymal stem cells in chronic spinal cord injury

, , , , &
Pages 516-522 | Received 02 Sep 2009, Accepted 20 Dec 2010, Published online: 12 Jul 2011

References

  • Eftekharpour E, Karimi-Abdolrezaee S, Fehlings MG. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008;24 (3&4):e18.
  • Wyndaele M, WyndaeleJJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord 2006;44:523–9.
  • Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial – National Acute Spinal Cord Injury Study. JAMA 1997;277:1597–604.
  • Ronsyn MW, Berneman ZN, Van Tendeloo VFI, et al. Can cell therapy heal a spinal cord injury? Spinal Cord 2008;46:532–9.
  • Hofsetter XCP, Hess SD, Widenfalk J, et al. Marrow stromal cells form guiding strands in injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002;99(4):2199–204.
  • Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999;49:377–91.
  • Skene JH. Axonal growth-associated proteins. Ann Rev Neurosci 1989;12:127–56.
  • Widenfalk J, Lundstromer K, Jubran M, et al. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or Kainic acid. J Neurosci 2001;21:3457–75.
  • Fu-jiang C, Shi-qing F. Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin Med J 2009;122(2):225–31.
  • Schwartz M. Autoimmune involvement in CNS trauma is beneficial if well controlled. Prog Brain Res 2000;128:259–63.
  • Ramer LM, Au E, Richter MW, et al. Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J Comp Neurol 2004;473:1–15.
  • Pearse DD, Marcillo AE, Oudega M, et al. Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J Neurotrauma 2004;21: 1223–39.
  • Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of in vitro expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 2002;69:925–33.
  • Koshizuka S, Okada S, Okawa A, et al. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 2004;63:64–72.
  • Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–7.
  • Lennon DP, Haynesworth SE, Young RG, et al. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995;219:211–22.
  • Richardson SM, Curran JM, Chen R, et al. The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-l-lactic acid (PLLA) scaffolds. Biomaterials 2006;27(22):4069–78.
  • Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18:1417–26.
  • Kang XQ, Zang WJ, Song TS, et al. Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. World J Gastroenterol 2005;11(22):3479–84.
  • Lee KD, Kuo TKC, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004;40(6):1275–84.
  • Ong S, Dai H, Leong KW. Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 2006;12:3477–85.
  • Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Bio Med 2004;229:623–31.
  • Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697–705.
  • Brazelton TR, Rossi FM, Keshet GI, et al. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775–9.
  • Corti S, Locatelli F, Donadoni C, et al. Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia. J Neurosci Res 2002;70:721–33.
  • Kitchel SH, Wang MY, Lauryssen CL. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 2005;57(4 Suppl):286–9.
  • Azzizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998;95:3908–13.
  • Abdallah BM, Haack-Sorensen M, Burns JS, et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite extensive proliferation. Biochem Biophys Res Commun 2005;326:527–38.
  • Du Y, Jenkins NA, Copeland NG. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005;106:3932–9.
  • Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 2002;22:6623–30.
  • Lu D, Mahmood A, Wang L, et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001;12:559–63.
  • Chen X, Li Y, Wang L, et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002;22:275–9.
  • Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838–43.
  • Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815–22.
  • Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000;28:875–84.
  • Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890–6.
  • Koda M, Okada S, Nakayama T, et al. Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice. Neuroreport 2005;16:1763–7.
  • Sykova E, Jendelova P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann N Y Acad Sci 2005;1049:146–60.
  • Chopp M, Zhang XH, Li Y, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 2000;11:3001–05.
  • Wu S, Suzuki Y, Ejiri Y, et al. Bone marrow stromal cells enhance differentiation of co-culture neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res 2003;72:343–51.
  • Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002;99:2199–304.
  • Zurita M, Vaquero J. Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation. Neurosci Lett 2006;402:51–6.
  • Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 2004;187:266–78.
  • Cizkova D, Rosocha J, Vanicky I, et al. Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat. Cell Mol Neurobiol 2006;26(7–8):1165–1178.
  • Hee Lee K, Suh-Kim H, Choi JS, et al. Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. Acta Neurobiol Exp 2007;67:13–22.
  • Sheth RN, Manzano G, Li X, et al. Transplanatation of human bone marrow-derived stromal cells in contused spinal cord of nude rats. J Neurosurg Spine 2008;8:153–62.
  • Deda H, Inci MC, Kürekçi AE, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008;10(6):565–74.
  • Urdzí ková L, Jendelová P, Glogarová K, et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promote recovery after spinal cord injury in rat. J Neurotrauma 2006;23:1379–91.
  • Sykova E, Urdzikova L, Jendelova P, et al. Bone marrow cells – a tool for spinal cord injury repair. Exp Neurol 2005;193: 261–2.
  • Lim HJ, Byeon YE, Ryu HH, et al. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injury in dogs. J Vet Sci 2007;8(3):275–82.
  • Mendes SC, Tibbe JM, Veenhof M, et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 2002;8(6):911–20.
  • Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006;15:1–13.
  • Hackam DG. Translating animal research into clinical benefit. BMJ 2007;334:163–4.
  • Ma M, Wei P, Wei T, et al. Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response. J Comp Neurol 2004;474:469–86.
  • Popovich PG, Wei P, Stokes BT. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 1997;377:443–64.
  • Ha Y, Yoon SH, Park SR, et al. Treatment of complete spinal cord injury patients receiving autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor – report of three cases. J Korean Neurosurg Soc 2004;35:459–64.
  • Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte macrophage-colony stimulating factor. Tissue Eng 2005;11(5/6):913–22.
  • Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage- colony stimulating factor: phase I/II clinical trial. Stem Cells 2007;25:2066–73.
  • Dobkin BH, Curt A, Guest J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 2006;20(1):5–13.
  • Lima C, Pratas-Vital J, Escada P, et al. Olfactory mucosa autografts in human spinal cord injury: a pilot study. J Spinal Cord Med 2006;29(3):191–203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.